Search peptides, terms, sources/
Research source · 2015

Afamelanotide for Erythropoietic Protoporphyria

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
74 adults in the European Union trial and 94 adults in the US trial, all with erythropoietic protoporphyria
Sample size
168
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Funded by Clinuvel Pharmaceuticals and others. Two moderate-sized trials with different durations. Registrations NCT01605136 and NCT00979745.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.